Antigemofilny factor cheloveka-m (ahf-m)

Roman name

Antihemophillic factor human-M (AHF-M)

The composition and the form of

1 bottle with sterile, liofilizirovannam powders for the preparation of injection solution includes factors such as blood clotting VIII 200-300, 400-600 or 800-1200 IU, together with the solvent-water injection in vials of 10 ml, bilateral needle and filter needle.

Dosing and Administration

In / in, and at speeds of 2-3 mL / min. The mode set individually controlled activity factor out VIII. The joint, muscle and tissue artistic methods level of factor VIII increase to a range of 10 to 20% (treatment duration of not less than 2-3 days); Teeth extraction or small transactions, not less than 30% (5 days), gastrointestinal artistic methods, not less than 50% (10-14 days); Extensive surgical interventions or intracranial krovoislianiah at no less than 60% (2-3 weeks). Initial dose (IU) looks as the product of the desired increase in the content of factor VIII (%), for weight (kg), which supports the dose is half primary. To prevent prolonged bleeding with severe hemophilia A, 12-25 IU / kg every 2-3 days.

Directory → Gematotropona funds → Coagulants (including factors such as blood clotting), gemostatiki → Antigemofilny factor cheloveka-m (ahf-m)

Antigemofilny factor cheloveka-m (ahf-m)

Roman name

The composition and the form of

Dosing and Administration

Storage conditions

Shelf life

All products of this group